Protocol source: These schedules reflect practice conventions summarized by a compounding source [18]
Lawsuits against Novo Nordisk claim that it failed to warn users of the risk of the following side effects: Vision loss or changes Gastroparesis (stomach paralysis) Neuropathy with gastroparesis Intestinal blockage (often requiring surgery to repair) Cyclical vomiting Pancreatic cancer Necrotizing pancreatitis Gallbladder disease Blood clots Has Trulicity Harmed You
The risk of hypoglycemia increases when you use the medication with other diabetes medications such as sulfonylureas and insulin
Electrolyte abnormalities other than hyperkalemia may be more likely when spironolactone is used in combination with other diuretic therapy
Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)
"New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases"
